Has anyone been 'volunteered ' for this new trial from Astra Zanaca?
Saruparib (AZD5305) vs Placebo in Men with Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents - EvoPAR-PR01
This is looking at whether adding a new drug on top of taking an Androgen Receptor Target Therapy (ARAT; such as abiraterone, darolutamide, enzalutamide) results in better outcomes (getting the cancer until control longer) than just taking an ARAT alone.
As this is a North American trial, would love to hear from others...